Quoi de neuf pour le traitement de l'hépatite B [What's new in the treatment of hepatitis B infection?]

Details

Serval ID
serval:BIB_09970C038C94
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Quoi de neuf pour le traitement de l'hépatite B [What's new in the treatment of hepatitis B infection?]
Journal
Revue Médicale Suisse
Author(s)
Bihl F., Alaei M., Girardin M., Negro F.
ISSN
1660-9379
Publication state
Published
Issued date
2009
Volume
5
Number
215
Pages
1720-1722, 1724
Language
french
Notes
Publication types: English Abstract ; Journal Article
Abstract
Although the number of available antiviral drugs for hepatitis B infection (VHB) today is higher than ever, treatment of chronic VHB infection is still often managed by specialists because of the complex natural history of this viral infection and of the risk of selecting viral strains that are resistant to therapy. Different clinical and virological aspects need to be considered to establish a correct indication for therapy. Once antiviral therapy has been started, patients need close monitoring to guarantee adequate compliance and to detect promptly the selection of viral variants resisting to therapy.
Keywords
Antiviral Agents/therapeutic use, Drug Resistance, Viral, Hepatitis B/drug therapy, Humans
Pubmed
Create date
11/02/2010 16:57
Last modification date
20/08/2019 12:31
Usage data